Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Takano S, Fukasawa M, Yamaguchi T, Maekawa S, Takahashi K, Uchimura K, Enomoto N. Takada H, et al. Among authors: yamaguchi t. Oncology. 2023;101(10):609-623. doi: 10.1159/000531111. Epub 2023 Jun 6. Oncology. 2023. PMID: 37279708
Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis.
Katoh R, Maekawa S, Osawa L, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Muraoka M, Suzuki Y, Sato M, Tatsumi A, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Enomoto N. Katoh R, et al. Among authors: yamaguchi t. Hepatol Res. 2023 Apr;53(4):280-288. doi: 10.1111/hepr.13861. Epub 2022 Dec 13. Hepatol Res. 2023. PMID: 36445119
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Takano S, Fukasawa M, Yamaguchi T, Maekawa S, Enomoto N. Takada H, et al. Among authors: yamaguchi t. Oncology. 2023;101(3):173-184. doi: 10.1159/000527752. Epub 2022 Dec 14. Oncology. 2023. PMID: 36516803
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease.
Suzuki Y, Maekawa S, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Takada H, Muraoka M, Sato M, Takano S, Fukasawa M, Yamaguchi T, Funayama S, Morisaka H, Onishi H, Enomoto N. Suzuki Y, et al. Among authors: yamaguchi t. J Gastroenterol Hepatol. 2023 Jun;38(6):921-929. doi: 10.1111/jgh.16154. Epub 2023 Mar 5. J Gastroenterol Hepatol. 2023. PMID: 36811251
A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population.
Yoshimura D, Fukasawa M, Yoda Y, Ohtaka M, Ooka T, Takano S, Kawakami S, Fukasawa Y, Kuratomi N, Harai S, Shimamura N, Hasegawa H, Imagawa N, Suzuki Y, Yoshida T, Kobayashi S, Sato M, Yamaguchi T, Maekawa S, Enomoto N. Yoshimura D, et al. Among authors: yamaguchi t. Diagnostics (Basel). 2024 Mar 20;14(6):651. doi: 10.3390/diagnostics14060651. Diagnostics (Basel). 2024. PMID: 38535071 Free PMC article.
Giant impurity effect on anomalous Hall effect of Mn3Sn.
Yano R, Kihara S, Yoneda M, Vu HTN, Suto H, Katayama N, Yamaguchi T, Kuwahara M, Suzuki MT, Saitoh K, Kashiwaya S. Yano R, et al. Among authors: yamaguchi t. J Chem Phys. 2024 May 14;160(18):184708. doi: 10.1063/5.0195211. J Chem Phys. 2024. PMID: 38738607
X-Ray Magnetic Circular Dichroism in Altermagnetic α-MnTe.
Hariki A, Dal Din A, Amin OJ, Yamaguchi T, Badura A, Kriegner D, Edmonds KW, Campion RP, Wadley P, Backes D, Veiga LSI, Dhesi SS, Springholz G, Šmejkal L, Výborný K, Jungwirth T, Kuneš J. Hariki A, et al. Among authors: yamaguchi t. Phys Rev Lett. 2024 Apr 26;132(17):176701. doi: 10.1103/PhysRevLett.132.176701. Phys Rev Lett. 2024. PMID: 38728732
9,116 results